Abstract:OBJECTIVE:To study the clinical effects of endovascular reconstruction versus bypass surgery for TASC II(trans-atlantic inter-society consensus II) C/D femoropopliteal artery lesion resulted from arteriosclerosis obliterans.METHODS:One hundred and three patients(119 limbs)accepted bypass surgery or endovascular therapy for TASCII C/D femoropopliteal artery lesion between January 2002 and December 2012 at our institution were retrospectively assessed.All the patients were diagnosed with arteriosclerosis obliterins, and all their Rutherford classifications were from 2 to 5 degrees.Among them there were 71 limbs treated by endovascular reconstruction and the other 48 limbs were treated with bypass surgery.We evaluated the short term clinical effect according to the condition when patients left the hospital, and evaluated the long term clinical effect according to the results of the patients' latest follow-up in 2014. Their clinical data before treatment, complication rates, death rates, hospital stays, short term and long term effects, reoperation rates, 1 to 10 years primary and secondary accumulative patency rates and limb salvage rates were compared.RESULTS:There was no significant difference between the bypass group and the endovascular group on the mean age and ankle brachial index before treatment [(67.1 ± 7.1) years(51 to 80 years) vs. (68.0 ± 9.4) years (49 to 91 years), P=0.561;(0.41 ± 0.23) vs. (0.40 ± 0.26), P=0.928]. There were more TASCII D patients in the bypass group than those in the endovascular group (P<0.001), and the rutherford classification was higher in the endovascular group than that in the bypass group. The difference in the mean follow-up between the bypass group and the endovascular group was not significant [(41.7 ± 23.6) months vs. (59.5 ± 41.6) months, P=0.065]. Five peri-operative complication cases occurred in the bypass group, including 2 cases of acute thrombosis,1 case of infection and 2 cases of heart failure, and only 1 complication case occurred in the endovascular group that was heart failure.The complication rate was higher in the bypass group than that in the endovascular group [10.4% vs. 1.4%, P=0.039]. And there was no death in both the groups.Compared with the endovascular group, the bypass group had a longer hospital stays [(13.2 ± 4.7) d vs.(6.5 ± 3.1) d, P<0.001], a higher reoperation rate (58.3% vs.31.0%,P=0.003), a better short term, obvious, and effective rate (25.0% vs. 9.9%, P=0.027), a worse long term deterioration rate (37.5% vs. 18.3%, P=0.019) and higher 1 to 10 years primary and secondary accumulative patency rates(P=0.001, P=0.001).There was no significant difference between the two groups on the increase of ankle brachial index [(0.34 ± .28) vs. (0.31 ± 0.23), P=0.371], and short term and long term total effective rates (89.6% vs.84.5%, P=0.426; 45.8% vs. 56.3%, P=0.260), and limb salvage rate (83.3% vs.94.4%, P=0.051).CONCLUSION:Endovascular therapy is a safe, effective and minimally invasive therapy for TASCII C/D femoropopliteal artery lesion resulted from arteriosclerosis obliterans.

Retrospective Evaluation of the Angiosome Concept for Endovascular Therapy in Patients with Critical Limb Ischemia

Endovascular Therapy Based on Angiosome Concept for Critical Lower Limb Ischemia

The Safety and Efficacy of Endovascular Treatment in Acute Ischemic Stroke Patients Caused by Large-Vessel Occlusion with Different Etiologies of Stroke: Data from ANGEL-ACT Registry

Impact on Clinical Outcomes—An Observational Study

Outcomes for Patients With Chronic Limb-Threatening Ischemia After Direct and Indirect Endovascular and Surgical Revascularization: A Meta-Analysis and Systematic Review

Infrapopliteal Arteries Revascularization in Patients with Limb Ischemic Ulcer

Analysis of results of the below-the-knee endovascular therapy for critical limb ischemia

Staged Endovascular Repair of Critical Limb Ischemia in High Risk Patients: the Procedural and Clinical Outcomes

Outcomes of Endovascular Recanalization Versus Autogenous Venous Bypass for Thromboangiitis Obliterans Patients with Critical Limb Ischemia Due to Tibioperoneal Arterial Occlusion

The Efficacy Analysis of Endovascular Intervention Therapy for Transatlantic Inter Society Consensus Type C and Type D Femoropopliteal Arteriosclerosis Lesion

Interventional Revascularization of the Lower Limbs Arteriosclerosis Obliterans:A Retrospective Study

[Comparison of the Clinical Efficacy of Endovascular Reconstruction Versus Bypass Surgery for Transatlantic Inter-Society Consensus II C/D Femoropopliteal Artery Lesion Resulted from Arteriosclerosis Obliterans].

Comparative Outcomes of Targeted Versus Nontargeted Angiosome Revascularization for Diabetic Foot Wounds Impact of Target Arterial Path on Wound Healing

Comparison of the clinical effects of endovascular therapy and bypass surgery for Trans-Atlantic Inter-Society ConsensusⅡC/D femoropopliteal artery disease

Endovascular intervention for infrapopliteal arterial ischemia

The Role of Intravascular Ultrasound in Limb Salvage: A Systematic Review and Meta-Analysis

IF12. Endovascular Intervention of Native Lower Extremity Chronic Total Occlusions in Critical Limb Ischemia Patients with Intermediate-to-Late Graft Failure

[Individual Revascularization for Treatment of Multilevel Arterial Occlusive Disease of Lower Extremity].

Perfusion increase in foot angiosomes: Comparison between direct and indirect revascularization of crural arteries

Meta-analysis of Intravascular Ultrasound-guided versus Angiography-guided Endovascular Treatment in Lower Extremity Artery Disease

The clinical efficacy of endovascular intervention for femoropopliteal arteriosclerosis